Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Caterina CINTI"'
Publikováno v:
Journal of Personalized Medicine, Vol 14, Iss 6, p 546 (2024)
In 2019, the International Consortium for Personalised Medicine (ICPerMed) developed a vision on how the use of personalized medicine (PM) approaches will promote “next-generation” medicine in 2030 more firmly centered on the individual’s perso
Externí odkaz:
https://doaj.org/article/5a979752ef514cb99327bc481f735b83
Autor:
Alessio Vizzoca, Gioia Lucarini, Elisabetta Tognoni, Selene Tognarelli, Leonardo Ricotti, Lisa Gherardini, Gualtiero Pelosi, Mario Pellegrino, Arianna Menciassi, Settimio Grimaldi, Caterina Cinti
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 17, p 9893 (2022)
Over the past few decades, finding more efficient and selective administration routes has gained significant attention due to its crucial role in the bioavailability, absorption rate and pharmacokinetics of therapeutic substances. The pulmonary deliv
Externí odkaz:
https://doaj.org/article/4192cc79dc3640d0b190a4e041a13251
Publikováno v:
Cancer Informatics, Vol 2016, Iss 15, Pp 45-64 (2016)
Externí odkaz:
https://doaj.org/article/545764c9bdaa4d14b11504a33a434792
Autor:
Zhijie Jiang, Caterina Cinti, Monia Taranta, Elisabetta Mattioli, Elisa Schena, Sakshi Singh, Rimpi Khurana, Giovanna Lattanzi, Nicholas F Tsinoremas, Enrico Capobianco
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0206686 (2018)
BackgroundIn melanoma, like in other cancers, both genetic alterations and epigenetic underlie the metastatic process. These effects are usually measured by changes in both methylome and transcriptome profiles, whose cross-correlation remains uncerta
Externí odkaz:
https://doaj.org/article/45b3350819814ca0b9537800d5e83ff0
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
This study highlights the relevance of network-guided controllability analysis as a precision oncology tool. Target controllability through networks is potentially relevant to cancer research for the identification of therapeutic targets. With refere
Externí odkaz:
https://doaj.org/article/2c73ddd402d6489cac55afc79aca49f2
Publikováno v:
International Journal of Molecular Sciences, Vol 15, Iss 4, Pp 5366-5387 (2014)
There is a growing concern in the population about the effects that environmental exposure to any source of “uncontrolled” radiation may have on public health. Anxiety arises from the controversial knowledge about the effect of electromagnetic fi
Externí odkaz:
https://doaj.org/article/8aea8b2162844abaabc728bb566c6794
Publikováno v:
Cancer Informatics, Vol 15 (2016)
Pan-cancer studies are particularly relevant not only for addressing the complexity of the inherently observed heterogeneity but also for identifying clinically relevant features that may be common to the cancer types. Immune system regulations usual
Externí odkaz:
https://doaj.org/article/5ca9877ae3c64219be882f9f73820b5b
Autor:
Enrico Capobianco, Antonio Mora, Dario La Sala, Annalisa Roberti, Nazar Zaki, Elarbi Badidi, Monia Taranta, Caterina Cinti
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95596 (2014)
Understanding the molecular mechanisms underlying multi-drug resistance (MDR) is one of the major challenges in current cancer research. A phenomenon which is common to both intrinsic and acquired resistance, is the aberrant alteration of gene expres
Externí odkaz:
https://doaj.org/article/84351f9cd5a14e0cadcf2ba8d4133153
Autor:
Ilaria Naldi, Monia Taranta, Lisa Gherardini, Gualtiero Pelosi, Federica Viglione, Settimio Grimaldi, Luca Pani, Caterina Cinti
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e98101 (2014)
Epigenetic events are critical contributors to the pathogenesis of cancer, and targeting epigenetic mechanisms represents a novel strategy in anticancer therapy. Classic demethylating agents, such as 5-Aza-2'-deoxycytidine (Decitabine), hold the pote
Externí odkaz:
https://doaj.org/article/d5198aac97564232b9c9bde385a1f099
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e17132 (2011)
Cytotoxic chemotherapy of cancer is limited by serious, sometimes life-threatening, side effects that arise from toxicities to sensitive normal cells because the therapies are not selective for malignant cells. So how can they be selectively improved
Externí odkaz:
https://doaj.org/article/81c931ba19404e169be4fe92b6191047